Rana P Singh

Prof Rana P Singh
Prof Rana Pratap Singh
Born01 December 1969
NationalityIndian
Alma materJawaharlal Nehru University, Colorado University
SpouseAruna Singh
ChildrenAyushi
Scientific career
InstitutionsJawaharlal Nehru University, Colorado University, Central University of Gujarat
Doctoral advisorProf A. Ramesha Rao
Websiterpscancerlab.com

Prof Rana P Singh is an Indian cancer scientist[1] and professor at the School of Life Sciences, Jawaharlal Nehru University (JNU), New Delhi.

Prof Singh is a university administrator[2] and acknowledged for creating new departments, schools and research centres in India.[3][4]

His own research encompasses a broad range of topics, including cancer stem cells, spheroids/organoids, DNA repair mechanisms, and the effects of microgravity on radiobiology.[5] Singh is also noted for his work in cell signaling, exploring the complex interactions that govern cellular behavior and cancer progression. His contributions to these areas have significantly advanced the understanding of cancer and its treatment.[6] He is highly cited scientist and has published over 100 research papers in world's leading scientific journals like Nature,[7][8] Oxford Academic,[9] Harvard Catalyst,[10] American Association for Cancer Research Journal[11] , etc

  1. ^ Tailor, Dhanir; Going, Catherine C.; Resendez, Angel; Kumar, Vineet; Nambiar, Dhanya K.; Li, Yang; Dheeraj, Arpit; LaGory, Edward Lewis; Ghoochani, Ali; Birk, Alisha M.; Stoyanova, Tanya; Ye, Jiangbin; Giaccia, Amato J.; Le, Quynh-Thu; Singh, Rana P.; Sledge, George W.; Pitteri, Sharon J.; Malhotra, Sanjay V. (February 2021). "Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer". British Journal of Cancer. 124 (3): 604–615. doi:10.1038/s41416-020-01137-4. ISSN 1532-1827. PMC 7851402. PMID 33139797.
  2. ^ "Sri Sri to give lecture at JNU on Nov 13". The Hindu. 5 November 2017.
  3. ^ "JNU To Start 4-year UG Programmes, Online Courses In Non-Technical Subjects". Outlook India. 20 November 2020.
  4. ^ "JNU to establish special centre for systems medicine". The Hindu. 19 November 2020. Retrieved 20 November 2020.
  5. ^ "Rana P Singh". Google Scholar.
  6. ^ "Press Trust Of India". www.ptinews.com.
  7. ^ Chandraker, Sandip Kumar; Lal, Mishri; Khanam, Farheen; Dhruve, Preeti; Singh, Rana P.; Shukla, Ravindra (25 May 2022). "Therapeutic potential of biogenic and optimized silver nanoparticles using Rubia cordifolia L. leaf extract". Scientific Reports. 12 (1): 8831. Bibcode:2022NatSR..12.8831C. doi:10.1038/s41598-022-12878-y. ISSN 2045-2322. PMC 9133087. PMID 35614187.
  8. ^ Tailor, Dhanir; Going, Catherine C.; Resendez, Angel; Kumar, Vineet; Nambiar, Dhanya K.; Li, Yang; Dheeraj, Arpit; LaGory, Edward Lewis; Ghoochani, Ali; Birk, Alisha M.; Stoyanova, Tanya; Ye, Jiangbin; Giaccia, Amato J.; Le, Quynh-Thu; Singh, Rana P.; Sledge, George W.; Pitteri, Sharon J.; Malhotra, Sanjay V. (February 2021). "Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer". British Journal of Cancer. 124 (3): 604–615. doi:10.1038/s41416-020-01137-4. ISSN 1532-1827. PMC 7851402. PMID 33139797.
  9. ^ Singh, R. P. (1 March 2003). "Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes". Carcinogenesis. 24 (3): 555–563. doi:10.1093/carcin/24.3.555. PMID 12663518.
  10. ^ "Akash Sabarwal | Harvard Catalyst Profiles | Harvard Catalyst". Connects.catalyst.harvard.edu.
  11. ^ Gu, Mallikarjuna; Singh, Rana P.; Dhanalakshmi, Sivanandhan; Mohan, Sarumathi; Agarwal, Rajesh (2006). "Differential effect of silibinin on E2F". Molecular Cancer Therapeutics. 5 (8): 2121–2130. doi:10.1158/1535-7163.MCT-06-0052. PMID 16928834.